Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer

Although it has been proposed that the beneficial effect of HER2-targeted therapy in HER2-negative breast cancer is associated with the molecular subtype conversion, the underlying mechanism and the clinical biomarkers are unclear. Our study showed that breast cancer stem cells (BCSCs) mediated HER2...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncotarget
المؤلفون الرئيسيون: Kim, Yun Gyoung, Yoon, Yi Na, Choi, Hyang Suk, Kim, Ji-Hyun, Seol, Hyesil, Lee, Jin Kyung, Seong, Min-Ki, Park, In Chul, Kim, Kwang Il, Kim, Hyun-Ah, Kim, Jae-Sung, Noh, Woo Chul
التنسيق: Artigo
اللغة:Inglês
منشور في: Impact Journals LLC 2017
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814176/
https://ncbi.nlm.nih.gov/pubmed/29464036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23528
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة